Mark Eisner - EVP and Chief Medical Officer at Vir Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP and Chief Medical Officer
Issuer Symbol
VIR on Nasdaq
All Insider Reports
All Insider Reports

Mark Eisner - trading volume in the past year for Vir Biotechnology, Inc.

Holdings reported by Mark Eisner for Vir Biotechnology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 154,024 $1,512,515 $9.82 25 Feb 2026 Direct
Stock Option (Right to Buy) 110,000 $122,400 $1.53 22 Feb 2026 Direct Common Stock

Transactions reported by Mark Eisner for Vir Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.